11 Results for "

FXIIa Inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "FXIIa Inhibitor" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-163348
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-4 (compound 22) is a potent, selective human FXIIa inhibitor with the IC50 of 0.032 μM, 0.30 μM, >50 μM for FXIIa, thrombin and FXIa, respectively. FXIIa-IN-4 can be used for study of anticoagulant .
loading...
    loading...
Cat. No.: HY-175735
CAS No.: 2563884-39-7
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Factor XI-IN-2 is a Factor XI activation inhibitor with an IC50 of 20 nM. Factor XI-IN-2 does not directly inhibit the enzymatic activity of FXIa, but specifically binds to the FXI enzyme precursor and allosterically inhibits the process by which it is activated by FXIIa. Factor XI-IN-2 inhibits thrombosis in the rabbit arteriovenous (AV) shunt thrombosis model. Factor XI-IN-2 can be used for the study of antithrombus .
loading...
    loading...
Cat. No.: HY-152150
CAS No.: 2866508-00-9
Target:  

Ser/Thr Protease

Research Areas:  

Metabolic Disease

Thrombin inhibitor 7 is a potent FXIIa inhibitor with IC50 values of 28 nM, >132 µM for FXIIa and FXIa, respectively. Thrombin inhibitor 7 shows low cytotoxicity .
loading...
    loading...
Cat. No.: HY-149397
CAS No.: 3052551-17-1
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-1-IN-2 (Compound 21) is a Factor XIIa inhibitor (Ki app: 62.2 nM). FXIIa-IN-1-IN-2 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-149396A
CAS No.: 3052551-20-6
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-1 hydrochloride is the hydrochloride of FXIIa-IN-1 (HY-149396). FXIIa-IN-1 (Compound 22) is a Factor XIIa inhibitor (Ki app: 97.8 nM). FXIIa-IN-1 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-163347
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

FXIIa-IN-3 (Compound 8) is a potent and selective Factor XIIa (FXIIa) inhibitor, with an IC50 of 0.045 μM. FXIIa-IN-3 also exhibits a substantial margin of selectivity against related serine proteases, including FXIa, FXa, and FIXa. FXIIa-IN-3 can be used for the research of thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-162646
CAS No.: 3047411-80-0
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-5 (Compound 4J) is an orally active, selective inhibitor for factor XIIa (FXIIa), with IC50 of 21 nM. FXIIa-IN-5 inhibits the intrinsic coagulation pathways, and exhibits anti-inflammatory and antithrombotic activity in Carrageenan (HY-125474)-induced mice thrombosis models. FXIIa-IN-5 exhibits moderate pharmacokinetic characteristics and slightly toxicity (at 100 mg/kg) .
loading...
    loading...
Cat. No.: HY-P10860
CAS No.: 2853605-24-8
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

cMCoFx1 is a potent and selective FXIIa cyclic peptide inhibitor. cMCoFx1 has high binding affinity (KD: 900 pM) and inhibitory activity (Ki: 370 pM) for FXIIa. cMCoFx1 can effectively inhibit endogenous clotting pathways, and cMCoFx1 is stable in serum and non-cytotoxic .
loading...
    loading...
Cat. No.: HY-184008
CAS No.: 3107571-66-1
Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

FXIIa-IN-6 is a potent, selective, and irreversible covalent inhibitor of Factor XIIa (FXIIa) with an IC50 of 2 nM. FXIIa-IN-6 exhibits ≥2,500-fold selectivity over related serine proteases. FXIIa-IN-6 exhibits favorable anticoagulant and anti-inflammatory activities and can be used in sepsis research .
loading...
    loading...
Cat. No.: HY-P991994

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

REGN9533 is a human-derived monoclonal antibody against FXII/FXIIa with high affinity for FXII, FXIIa and β-FXIIa. REGN9533 selectively inhibits the intrinsic coagulation pathway and FXIIa-driven plasma kallikrein activity. REGN9533 is applicable to FXIIa-related diseases such as thrombosis and hereditary angioedema .
loading...
    loading...
Cat. No.: HY-P991993

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

AB054 is a humanized monoclonal antibody targeting factor XII (FXII). AB054 inhibits FXII activation and FXIIa activity through specific binding to the catalytic domain of FXII, and exerts antithrombotic effects in a concentration-dependent manner. AB054 can be used in studies related to thrombosis .
loading...
    loading...
  • 1